SPINAL MYOCLONUS - SUCCESSFUL TREATMENT WITH THE COMBINATION OF SODIUM VALPROATE AND L-5-HYDROXYTRYPTOPHAN

被引：4
|
作者：
JIMENEZJIMENEZ, FJ
ROLDAN, A
ZANCADA, F
MOLINAARJONA, JA
FERNANDEZBALLESTEROS, A
SANTOS, J
机构：
[1] HOSP NA SRA,UNIDAD NEUROL,CACERES,SPAIN
[2] HOSP NA SRA,SERV MED INTERNA,CACERES,SPAIN
来源：
CLINICAL NEUROPHARMACOLOGY | 1991年 / 14卷 / 02期
关键词：
MYOCLONUS; SEGMENTAL MYOCLONUS; SPINAL MYOCLONUS; SODIUM VALPROATE; L-5-HYDROXYTRYPTOPHAN; SEROTONERGIC PATHWAYS;
D O I：
10.1097/00002826-199104000-00009
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We describe a 37-year-old man with spinal segmental myoclonus characterized by symmetric, rhythmic contractions of the abdomen with a frequency ranging between 100 and 150/min. The combination of sodium valproate and L-5-hydroxytryptophan was useful to control the myoclonus. We comment on the possible role of the serotonergic system in this syndrome.
引用
收藏
页码：186 / 190
页数：5
相关论文
共 50 条
  • [1] TREATMENT OF ACTION MYOCLONUS WITH L-5-HYDROXYTRYPTOPHAN
    VANWOERT, MH
    SETHY, VH
    COLEMAN, M
    NEUROLOGY, 1974, 24 (04) : 387 - 387
  • [2] TREATMENT OF INTENTION MYOCLONUS WITH PAROXETINE ALONE OR IN COMBINATION WITH L-5-HYDROXYTRYPTOPHAN AND CARBIDOPA
    MAGNUSSEN, I
    MONDRUP, K
    OLIVARIUS, BD
    LADEMANN, A
    ACTA NEUROLOGICA SCANDINAVICA, 1982, 65 (03): : 232 - 232
  • [3] THERAPY OF MYOCLONUS WITH L-5-HYDROXYTRYPTOPHAN
    VANWOERT, MH
    SETHY, VH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1975, 17 (02) : 246 - 246
  • [4] REFRACTORY MYOCLONUS AND L-5-HYDROXYTRYPTOPHAN THERAPY
    YOUNG, RR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (15): : 1569 - 1569
  • [5] MYOCLONUS, ATAXIA, AND HYPOVENTILATION - RESPONSE TO L-5-HYDROXYTRYPTOPHAN
    FEIT, H
    KIRKPATRICK, J
    VANWOERT, MH
    PANDIAN, G
    NEUROLOGY, 1983, 33 (01) : 109 - 112
  • [6] L-5-HYDROXYTRYPTOPHAN (L-5HTP) AND INTENTION MYOCLONUS
    WOERT, MHV
    SETHY, VH
    PHARMACOLOGIST, 1974, 16 (02): : 244 - 244
  • [7] THERAPY OF MYOCLONUS WITH L-5-HYDROXYTRYPTOPHAN PLUS MK 486
    VANWOERT, MH
    SETHY, VH
    BOWERS, MB
    NEUROLOGY, 1975, 25 (04) : 362 - 362
  • [8] L-5-HYDROXYTRYPTOPHAN IN THE TREATMENT OF ANXIETY DISORDERS
    KAHN, RS
    WESTENBERG, HGM
    JOURNAL OF AFFECTIVE DISORDERS, 1985, 8 (02) : 197 - 200
  • [9] L-5-HYDROXYTRYPTOPHAN ALONE AND IN COMBINATION WITH A PERIPHERAL DECARBOXYLASE INHIBITOR IN THE TREATMENT OF DEPRESSION
    ZMILACHER, K
    BATTEGAY, R
    GASTPAR, M
    NEUROPSYCHOBIOLOGY, 1988, 20 (01) : 28 - 35
  • [10] TREATMENT OF MYOCLONUS WITH L-5-HYDROXYTRYPTOPHAN AND CARBIDOPA - CLINICAL, ELECTRO-PHYSIOLOGICAL, AND BIOCHEMICAL OBSERVATIONS
    THAL, LJ
    SHARPLESS, NS
    WOLFSON, L
    KATZMAN, R
    ANNALS OF NEUROLOGY, 1980, 7 (06) : 570 - 576
12345